In this review, the authors discuss “actinopathies” in terms of the clinical aspects and cellular mechanisms, with a focus on the effect of these mutations on neutrophil function.…
Mark Ballow, MD, of the University of South Florida, and Jolan Walter, MD, PhD, of the University of South Florida and Johns Hopkins All Children’s Hospital, discuss COVID-19…
NEW YORK (Reuters Health) – The current U.S. system for allocating donated livers – which is based on the Model for End-Stage Liver Disease (MELD) score – is…
NEW YORK (Reuters Health) – After brain death in potential lung donors, a “lung protective” strategy can increase the odds that the lungs will be viable for transplant,…
NEW YORK (Reuters Health) – Putting patients on dialysis before they’re symptomatic offers no survival benefit; on the contrary, it may increase their risk of death, according to…
NEW YORK (Reuters Health) – Rates of acute rejection of lung transplants are not improved when sirolimus is added to the immunosuppressive regimen instead of azathioprine, a multicenter…
NEW YORK (Reuters Health) – Major surgery often leads to transient thyroid hormone derangements. When it does, short-duration T3 therapy has no apparent benefit, according to a new…
NEW YORK (Reuters Health) – Azithromycin is not only an effective treatment for bronchiolitis obliterans syndrome (BOS) that occurs in many lung transplant patients, it can also prevent…
NEW YORK (Reuters Health) – Hospitalized cirrhotics are at increased risk for venous thromboembolism (VTE) up until age 45 but not afterward, a new study suggests. Patients hospitalized…
NEW YORK (Reuters Health) – Solid organ recipients often develop invasive fungal infections months or even years after transplant, according to registry data from the U.S. Depending on…
NEW YORK (Reuters Health) – Belatacept-based immunosuppression after kidney transplantation allows for better renal function compared to cyclosporine, with similar graft and patient survival, phase III trial results…
NEW YORK (Reuters Health) – In a study of living donor liver transplantations with left side grafts, no significant difference in survival was seen when grafts
